Skip to main content
Medication leaflets
  • Catalogues⌄
    • MedicinesMedicines for human use
    • Active substancesBrowse by active ingredient
    • ATCExplore therapeutic groups
    • VeterinaryAnimal medicines and species
  • Română
  • English
  • Deutsch

Enter at least 3 characters. Use the arrow keys for suggestions and Enter to select.

  1. Medication leaflets
  2. ATC
  3. J05AD01

Anatomical Therapeutic Chemical • J05AD01 • foscarnet

‹ All groups
  • A
  • B
  • C
  • D
  • G
  • H
  • J
  • L
  • M
  • N
  • P
  • R
  • S
  • V
  1. J
  2. J05
  3. J05A
  4. J05AD

J Antiinfectives for systemic use

J01 Antibacterials for systemic use

J02 Antimycotics for systemic use

J04 Antimycobacterials

J05 Antivirals for systemic use

J05A Direct acting antivirals

J05AA Thiosemicarbazones
J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
J05AC Cyclic amines
J05AD Phosphonic acid derivatives
J05AD01 foscarnet Indicated for: cytomegalovirus infection
J05AE Protease inhibitors
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
J05AG Non-nucleoside reverse transcriptase inhibitors
J05AH Neuraminidase inhibitors
J05AJ Integrase inhibitors
J05AP Antivirals for treatment of HIV infections
J05AR Antivirals for treatment of HIV infections, combinations
J05AX Other antivirals

J06 Immune sera and immunoglobulins

J07 Vaccines

Medicines are classified using the system known as ATC.
Classification is based on the organ or system on which the medicine acts, its therapeutic effects and the chemical structure of its active substance.

Copyright © prospecte.ro 2019-2026. All rights reserved.

We do not guarantee the accuracy, completeness, or timeliness of the displayed data.

The information on this site is for informational purposes only and does not replace the advice of a doctor or pharmacist.

For diagnosis, treatment, dosage, or side effects, consult your doctor, pharmacist, or the official leaflet.

Official sources

Sources:

  • CNAS
  • ANMDMR
  • EMA
  • ICBMV
  • About
  • Editorial policy
  • Methodology
  • Corrections
  • Contact